COMMUNIQUÉS West-GlobeNewswire

-
Merit Medical Systems to Announce Second Quarter Results on July 25, 2019
09/07/2019 -
Green Growth Brands to Create First '360 Degree' Cannabis Company Through a Combination with MXY Holdings LLC
09/07/2019 -
United Health Products Issues Shareholder Update
09/07/2019 -
Tennesseans Reaping Benefits of Novel Clinical Trials Network in Year One of Operation
09/07/2019 -
NuMe TMS Clinics in Salt Lake City and Boise Add FDA-Cleared Treatment for Major Depressive Disorder (MDD) and Obsessive-Compulsive Disorder (OCD) to Services
09/07/2019 -
Chiesi Group confirms positive trend to date for 2019
09/07/2019 -
Langley BC Cannabis Announces that Health Canada has completed a preliminary and high-level review of their license application
09/07/2019 -
AXIM® Biotechnologies Signs Licensing Agreement With Leading Gum Distributor to Expand Nutraceutical Division
09/07/2019 -
Vaccex, Inc is pleased to announce the formal engagement of Dr. Per Horn as President and Chief Executive Officer
09/07/2019 -
Annovis Appoints Jeffrey McGroarty Chief Financial Officer
09/07/2019 -
Marrone Bio Innovations’ BioUnite™ program offers new solutions to California growers
09/07/2019 -
Adamis Pharmaceuticals Provides Update on U.S. Retail Launch of SYMJEPI
09/07/2019 -
Medtainer Inc. Announces Custom Orders from Planet 13
09/07/2019 -
AgraFlora Organics déploie sa technologie brevetée de bouchon distributeur de cannabinoïdes de qualité pharmaceutique dans un centre d'embouteillage certifié GMP de Toronto
09/07/2019 -
REPEAT - AgraFlora Organics Deploys Patented, Pharma-Grade Cannabinoid Delivery Bottle Cap Technology at GMP Certified Toronto, ON Bottling Facility
09/07/2019 -
CorMedix Receives Encouraging FDA Feedback on Neutrolin® LOCK-IT-100 Data
09/07/2019 -
California Tech Startup Ocutrx Vision Technologies Steals the Show at Prestigious Retina Conference
09/07/2019 -
Coloplast completes its SenSura® Mio ostomy care range with new innovative products for premature babies and kids
09/07/2019 -
Cognition Therapeutics Receives $3.3 Million NIA Grant to Conduct qEEG Study of Elayta™ with World-Leading Alzheimer’s Biomarker Experts
09/07/2019
Pages